Key Details
Price
$234.80Last Dividend
$0.27Annual Revenue
$23.89 BAnnual EPS
$6.38Annual ROE
9.20%Beta
0.67Events Calendar
Next earnings date:
Jan 29, 2025Recent quarterly earnings:
Oct 22, 2024Recent annual earnings:
Jan 30, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 27, 2024Next split:
N/ARecent split:
Oct 02, 2023Analyst ratings
Recent major analysts updates
Screeners with DHR included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Danaher (DHR) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.
#Morningstar #TopStocks #InvestingInStocks These businesses have strong competitive edges and produce consistent cash flow. 00:00 Introduction 00:46 Danaher DHR 01:36 Paychex PAYX 02:17 Equifax EFX I'm Susan Dziubinski from Morningstar.
On December 10, 2024, Danaher Corporation (NYSE: DHR) revealed that its Board of Directors has approved a quarterly cash dividend of $0.27 per share of common stock. This dividend will be paid on January 31, 2025, to those who are on record by December 27, 2024. Danaher is a prominent global innovator in life sciences and diagnostics, dedicated to enhancing human health through science and technology.
DHR is facing challenges in its operations because the Life Sciences sector is not performing well. Additionally, increasing costs are another worry for the company.
Since 2017, Danaher has kept a net earning margin of over 15%. In the third quarter of 2024, the company's liabilities-to-assets ratio was 36.36%, the lowest it has been since 2017. With its biggest customers cutting back on extra COVID-19-related products, Danaher anticipates an increase in sales.
Danaher Corporation (NYSE:DHR) will participate in the Annual Evercore ISI HealthCONx Healthcare Conference on December 4, 2024, at 3:25 PM ET. Rainer Blair, the President and CEO, will be representing the company. Vijay Kumar from Evercore ISI will also be part of the conference call.
On November 26, 2024, Danaher Corporation (NYSE: DHR) shared that their President and CEO, Rainer M. Blair, will speak at the Evercore ISI HealthCONx Conference. This event will take place in Coral Gables, Florida, on Wednesday, December 4, 2024, at 3:25 p.m.
Danaher announced decent earnings for the third quarter, and "cautious" is likely the best word to describe the report. The company is back to growing, and their future outlook appears positive, but the management is hesitant to provide specific figures to support their optimism. I discuss the possible reasons for this cautious approach in the article.
On Tuesday, Danaher Corp DHR announced that its sales for the third quarter reached $5.79 billion, which is a 3% increase compared to the same period last year. This figure surpassed the expected consensus of $5.59 billion.
DHR's earnings and sales for the third quarter exceeded expectations, thanks to the strong results from its Life Sciences and Diagnostics divisions.
FAQ
- What is the primary business of Danaher?
- What is the ticker symbol for Danaher?
- Does Danaher pay dividends?
- What sector is Danaher in?
- What industry is Danaher in?
- What country is Danaher based in?
- When did Danaher go public?
- Is Danaher in the S&P 500?
- Is Danaher in the NASDAQ 100?
- Is Danaher in the Dow Jones?
- When was Danaher's last earnings report?
- When does Danaher report earnings?
- Should I buy Danaher stock now?